Cysview Approval History
FDA Approved: Yes (First approved May 28, 2010)
Brand name: Cysview
Generic name: hexaminolevulinate
Dosage form: for Intravesical Solution
Previous Name: Hexvix
Company: Photocure ASA
Treatment for: Diagnosis and Investigation
Cysview (hexaminolevulinate HCl) is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder.
Development History and FDA Approval Process for Cysview
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.